References
- WeledjiEPBenefits and risks of splenectomyInt. J. Surg.201412 113 11910.1016/j.ijsu.2013.11.017
- GarberBGMmathBPFairfull-SmithRJYelleJDManagement of adult splenic injuries in Ontario: a population-based studyCan. J. Surg. J. Can. De. Chir.200043283288
- BisharatNOmariHLaviIRazRRisk of infection and death among post-splenectomy patientsJ. Infect.20014318218610.1053/jinf.2001.0904
- KingHShumackerHBJr.Splenic studies. I. Susceptibility to infection after splenectomy performed in infancyAnn. Surg.195213623924210.1097/00000658-195208000-00006
- WilliamBMThawaniNSae-TiaSCorazzaGRHyposplenism: a comprehensive review. Part II: clinical manifestations, diagnosis, and managementHematology200712899810.1080/10245330600938463
- de PunderKPruimboomLStress induces endotoxemia and low-grade inflammation by increasing barrier permeabilityFront. Immunol.2015622310.3389/fimmu.2015.00223
- AndreasenASet al.Human endotoxemia as a model of systemic inflammationCurr. Med. Chem.2008151697170510.2174/092986708784872393
- VaishnaviCTranslocation of gut flora and its role in sepsisIndian J. Med. Microbiol.20133133434210.4103/0255-0857.118870
- CaniPDet al.Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in miceDiabetes2008571470148110.2337/db07-1403
- MakkiKDeehanECWalterJBackhedFThe impact of dietary fiber on gut microbiota in host health and diseaseCell Host Microbe20182370571510.1016/j.chom.2018.05.012
- DelzenneNMNeyrinckAMBackhedFCaniPDTargeting gut microbiota in obesity: effects of prebiotics and probioticsNat. Rev. Endocrinol.2011763964610.1038/nrendo.2011.126
- Jovanovich, A., Isakova, T. & Stubbs, J. Microbiome and cardiovascular disease in CKD. Clin. J. Am. Soc. Nephrol.10.2215/CJN.12691117 (2018).
- CandelaMBiagiEMaccaferriSTurroniSBrigidiPIntestinal microbiota is a plastic factor responding to environmental changesTrends Microbiol.20122038539110.1016/j.tim.2012.05.003
- DandonaPAljadaAChaudhuriAMohantyPGargRMetabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammationCirculation20051111448145410.1161/01.CIR.0000158483.13093.9D
- RossRAtherosclerosis—an inflammatory diseaseN. Engl. J. Med.199934011512610.1056/NEJM199901143400207
- WellenKEHotamisligilGSInflammation, stress, and diabetesJ. Clin. Investig.20051151111111910.1172/JCI25102
- OttSJet al.Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel diseaseGut20045368569310.1136/gut.2003.025403
- de la Cuesta-ZuluagaJCorrales-AgudeloVCarmonaJAAbadJMEscobarJSBody size phenotypes comprehensively assess cardiometabolic risk and refine the association between obesity and gut microbiotaInt. J. Obes.20184242443210.1038/ijo.2017.281
- TaurYet al.The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantationBlood20141241174118210.1182/blood-2014-02-554725
- QinNet al.Alterations of the human gut microbiome in liver cirrhosisNature2014513596410.1038/nature13568
- WangJet al.Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patientsFront. Microbiol.20178222210.3389/fmicb.2017.02222
- LueddeMet al.Heart failure is associated with depletion of core intestinal microbiotaESC Heart Fail.2017428229010.1002/ehf2.12155
- Del ChiericoFet al.Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approachHepatology20176545146410.1002/hep.28572
- GonaiMet al.Galacto-oligosaccharides ameliorate dysbiotic Bifidobacteriaceae decline in Japanese patients with type 2 diabetesBenef. Microbes2017870571610.3920/BM2016.0230
- WadeWFKingRGGrandjeanCWadeTKJustementLBMurine marginal zone B cells play a role in Vibrio cholerae LPS antibody responsesPathog. Dis.20147015315710.1111/2049-632X.12085
- WeibergDet al.Participation of the spleen in the IgA immune response in the gutPLoS ONE201813e020524710.1371/journal.pone.0205247
- SpencerJDoganAA common migratory highway between human spleen and mucosa-associated lymphoid tissues; data from nature’s own experimentsMucosal Immunol.2009238038210.1038/mi.2009.91
- StoelMet al.Restricted IgA repertoire in both B-1 and B-2 cell-derived gut plasmablastsJ. Immunol.20051741046105410.4049/jimmunol.174.2.1046
- RosadoMMet al.From the fetal liver to spleen and gut: the highway to natural antibodyMucosal Immunol.2009235136110.1038/mi.2009.15
- ThevaranjanNet al.Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunctionCell Host Microbe20182357010.1016/j.chom.2018.03.006
- GiannelliVet al.Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosisWorld J. Gastroenterol.201420167951681010.3748/wjg.v20.i45.16795
- TerawakiHet al.Low-grade endotoxemia contributes to chronic inflammation in hemodialysis patients: examination with a novel lipopolysaccharide detection methodTher. Apher. Dial.20101447748210.1111/j.1744-9987.2010.00815.x
- JayashreeBet al.Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetesMol. Cell. Biochem.201438820321010.1007/s11010-013-1911-4
- Blaess, M. et al. NB 06: from a simple lysosomotropic aSMase inhibitor to tools for elucidating the role of lysosomes in signaling apoptosis and LPS-induced inflammation. Eur. J. Med. Chem.10.1016/j.ejmech.2017.09.021 (2017).
- MaesMMihaylovaILeunisJCIncreased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeabilityJ. Affect. Disord.20079923724010.1016/j.jad.2006.08.021
- MaesMMihaylovaILeunisJCIncreased serum IgM antibodies directed against phosphatidyl inositol (Pi) in chronic fatigue syndrome (CFS) and major depression: evidence that an IgM-mediated immune response against Pi is one factor underpinning the comorbidity between both CFS and depressionNeuro Endocrinol. Lett.200728861867
- WiedermannCJet al.Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck StudyJ. Am. Coll. Cardiol.1999341975198110.1016/S0735-1097(99)00448-9
- BergheimIet al.Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxinJ. Hepatol.20084898399210.1016/j.jhep.2008.01.035
- KalambokisGNTsianosEVRifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosisHepatology20125565565610.1002/hep.24751
- Wu, T. R. et al. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut. gutjnl-20170315-458 (2018). (Epub ahead of print).
- ChangCJet al.Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiotaNat. Commun.2015610.1038/ncomms8489
- SegataNet al.Metagenomic biomarker discovery and explanationGenome Biol.20111210.1186/gb-2011-12-6-r60
- LangilleMGet al.Predictive functional profiling of microbial communities using 16S rRNA marker gene sequencesNat. Biotechnol.20133181482110.1038/nbt.2676